It is achieved by suppressing the deubiquitinating of CSN5 and leads to PD-L1 ubiquitination and degradation, reactivating cytotoxic T-cells and reducing immunosuppressive cells in the tumor microenvironment [210]. This evidence concerns the gene CD274 and neoplasm.